Abeona Therapeutics Inc (NASDAQ:ABEO)’s traded shares stood at 2.58 million during the last session, with the company’s beta value hitting 1.54. At the close of trading, the stock’s price was $6.45, to imply an increase of 0.47% or $0.03 in intraday trading. The ABEO share’s 52-week high remains $7.32, putting it -13.49% down since that peak but still an impressive 39.07% since price per share fell to its 52-week low of $3.93.
Analysts have given a consensus recommendation of Buy for Abeona Therapeutics Inc (ABEO), translating to a mean rating of 1.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give ABEO a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.38.
Abeona Therapeutics Inc (NASDAQ:ABEO) trade information
After registering a 0.47% upside in the last session, Abeona Therapeutics Inc (ABEO) has traded red over the past five days. The 5-day price performance for the stock is 19.67%, and 22.16% over 30 days. With these gigs, the year-to-date price performance is 15.80%.
The extremes give us $16 and $20 for target low and target high price respectively. As such, ABEO has been trading -210.08% off suggested target high and -148.06% from its likely low.
Revenue forecast for the current quarter as set by 7 analysts is 21.71M. Meanwhile, for the current quarter, a total of 7 analyst(s) estimate revenue growth to 6.61M.
ABEO Dividends
Abeona Therapeutics Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Abeona Therapeutics Inc (ABEO) shares. Going by data provided on Dec 31, 2024 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 1.23 shares. This is just over 2.41% of the total shares, with a market valuation of $7.95 million. Data from the same date shows that the other fund manager holds a little less at 678.1, or 1.33% of the shares, all valued at about 4.37 million.
